Shanghai ZJ Bio-Tech Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-34.3	-127.46	-136.86	760.27	758.52
Depreciation & Amortization	66.08	67.71	66.69	60.24	24.84
Other Amortization	1.02	1.42	0.59	0.08	-
Loss (Gain) From Sale of Assets	-0.04	-0.04	-	-0.03	-
Asset Writedown & Restructuring Costs	-12.71	22.53	1.15	0.59	0.03
Loss (Gain) From Sale of Investments	-3.82	-0.06	-	-	-
Provision & Write-off of Bad Debts	-	8.41	1.36	6.35	5.38
Other Operating Activities	30.42	134.73	169.99	-62.76	28.33
Change in Accounts Receivable	27.88	37.31	114.77	12.17	-25.19
Change in Inventory	10.51	36.37	31.72	-297.19	-172.51
Change in Accounts Payable	-10.98	-81.05	-304.21	104.49	16.72
Change in Other Net Operating Assets	0.73	0.98	0.61	1.18	5.86
Operating Cash Flow	66.85	77.59	-81.88	584.97	641.94
Operating Cash Flow Growth	-13.84%	-	-	-8.87%	-43.78%
Capital Expenditures	-1.99	-19.49	-81.15	-74.56	-498.06
Sale of Property, Plant & Equipment	0.63	0.01	1.14	0.06	-
Investment in Securities	-305.36	0.06	2.32	-1.53	-21
Investing Cash Flow	-306.72	-19.42	-77.69	-76.02	-519.06
Long-Term Debt Issued	297	-	-	-	-
Long-Term Debt Repaid	-2.98	-2.51	-3.65	-3.75	-
Net Debt Issued (Repaid)	294.02	-2.51	-3.65	-3.75	-
Issuance of Common Stock	-	-	-	-	1,959
Repurchase of Common Stock	-	-35.33	-	-102.03	-
Common Dividends Paid	-3.03	-20.88	-230.74	-265.62	-311.53
Other Financing Activities	-261.34	-	-	-	-19.3
Financing Cash Flow	29.64	-58.72	-234.39	-371.4	1,628
Foreign Exchange Rate Adjustments	-23.01	14.44	15.77	74.35	-19.82
Net Cash Flow	-233.24	13.89	-378.19	211.9	1,731
Free Cash Flow	64.86	58.1	-163.03	510.41	143.88
Free Cash Flow Growth	11.63%	-	-	254.76%	-86.52%
Free Cash Flow Margin	51.96%	32.52%	-59.43%	21.94%	7.13%
Free Cash Flow Per Share	0.36	0.30	-0.85	2.64	0.76
Cash Income Tax Paid	-12.18	17.21	52.97	188.93	261.3
Levered Free Cash Flow	42.43	42.13	-98.85	410.82	-144.71
Unlevered Free Cash Flow	42.43	42.35	-98.63	411.11	-144.71
Change in Working Capital	20.21	-29.64	-184.81	-179.76	-175.17

Source: S&P Global Market Intelligence. Standard template. Financial Sources.